Accessory protein-like is essential for IL-18-mediated signaling

被引:63
作者
Cheung, H
Chen, NJ
Cao, ZD
Ono, N
Ohashi, PS
Yeh, WC
机构
[1] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[2] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Adv Med Discovery Inst, Toronto, ON, Canada
[3] Amgen Inc, San Francisco, CA USA
关键词
D O I
10.4049/jimmunol.174.9.5351
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-18 is an essential cytokine for both innate and adaptive immunity. Signaling by IL-18 requires IL-18R alpha, which binds specifically to the ligand and contains sequence homology to IL-1R and TLRs. It is well established that IL-1R signaling requires an accessory cell surface protein, AcP. Other accessory proteins also exist with roles in regulating TLR signaling, but some have inhibitory functions. An AcP-like molecule (AcPL) has been identified with the ability to cooperate with IL-18Ra in vitro; however, the physiological function of AcPL remains unknown. In this study, we demonstrate that IL-18 signals are abolished in AcPL-deficient mice and cells. Splenocytes from mutant mice fail to respond to IL-18-induced proliferation and IFN-gamma production. In particular, Th1 cells lacking AcPL fail to produce IFN-gamma in response to IL-18. AcPL-deficient neutrophils also fail to respond to IL-18-induced activation and cytokine production. Furthermore, AcPL is required for NK-mediated cytotoxicity induced by in vivo IL-18 stimulation. However, AcPL is dispensable for the activation or inhibition of IL-1R and the various TLR signals that we have examined. These results suggest that AcPL is a critical and specific cell surface receptor that is required for IL-18 signaling.
引用
收藏
页码:5351 / 5357
页数:7
相关论文
共 34 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   Cloning and expression of interleukin-18 binding protein [J].
Aizawa, Y ;
Akita, K ;
Taniai, M ;
Torigoe, K ;
Mori, T ;
Nishida, Y ;
Ushio, S ;
Nukada, Y ;
Tanimoto, T ;
Ikegami, H ;
Ikeda, M ;
Kurimoto, M .
FEBS LETTERS, 1999, 445 (2-3) :338-342
[3]   Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling [J].
Born, TL ;
Thomassen, E ;
Bird, TA ;
Sims, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) :29445-29450
[4]   ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance [J].
Brint, EK ;
Xu, DM ;
Liu, HY ;
Dunne, A ;
McKenzie, ANJ ;
O'Neill, LAJ ;
Liew, FY .
NATURE IMMUNOLOGY, 2004, 5 (04) :373-379
[5]   TARF6 is a signal transducer for interleukin-1 [J].
Cao, ZD ;
Xiong, J ;
Takeuchi, M ;
Kurama, T ;
Goeddel, DV .
NATURE, 1996, 383 (6599) :443-446
[6]   IL-18 receptors, their role in ligand binding and function: Anti-IL-1RAcPL antibody, a potent antagonist of IL-18 [J].
Debets, R ;
Timans, JC ;
Churakowa, T ;
Zurawski, S ;
Malefyt, RD ;
Moore, KW ;
Abrams, JS ;
O'Garra, A ;
Bazan, JF ;
Kastelein, RA .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :4950-4956
[7]   Overview of interleukin-18:: more than an interferon-γ inducing factor [J].
Dinarello, CA ;
Novick, D ;
Puren, AJ ;
Fantuzzi, G ;
Shapiro, L ;
Mühl, H ;
Yoon, DY ;
Reznikov, LL ;
Kim, SH ;
Rubinstein, M .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 63 (06) :658-664
[8]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[9]   A proinflammatory role for IL-18 in rheumatoid arthritis [J].
Gracie, JA ;
Forsey, RJ ;
Chan, WL ;
Gilmour, A ;
Leung, BP ;
Greer, MR ;
Kennedy, K ;
Carter, R ;
Wei, XQ ;
Xu, DM ;
Field, M ;
Foulis, A ;
Liew, FY ;
McInnes, IB .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (10) :1393-1401
[10]   MOLECULAR-CLONING AND CHARACTERIZATION OF A 2ND SUBUNIT OF THE INTERLEUKIN-1 RECEPTOR COMPLEX [J].
GREENFEDER, SA ;
NUNES, P ;
KWEE, L ;
LABOW, M ;
CHIZZONITE, PA ;
JU, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (23) :13757-13765